$30.61 -0.04 (-0.13%)
2/10/2012 4:00 PM

ViroPharma, Inc. (NASDAQ:VPHM)

CAPS Rating: 4 out of 5

A biopharmaceutical company dedicated to the development and commercialization of products that address serious infectious diseases, with a focus on products used by physician specialists or in hospital settings.

Featured Broker Partners


Advertisement